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Abstract
Cholangiocytes are the cells lining the biliary tree from canals of Hering to larger bile ducts. By 
morphology, they are divided in small and large cholangiocytes, which result heterogeneous at 
functional and proliferative levels. Proliferating cholangiocytes acquire a neuroendocrine phe-
notype, modulated by several factors including neurotrophins. Brain Derivated Neurotrophic 
Factor (BDNF) is a neurotrophin expressed in the nervous system and also in different types of 
epithelial and progenitor cells. The aim of the present study is to detect the expression of BDNF 
and of its two receptors (TrKB and p75NT, or p75NTR) in normal and bile duct ligated (BDL) 
rat livers. 
In normal and BDL livers, BDNF and its receptors are expressed by small and large cholan-
giocytes and by hepatic progenitors cells. In cholangiocytes, the expression of BDNF and of its 
receptors changes after different BDL timing. After one or two weeks of BDL, both BDNF and 
TrKB and p75NT receptors are highly expressed, while after BDL for three weeks BDNF expres-
sion is drastically reduced and p75NT receptor prevails on TrKB. The expression of BDNF and 
of its receptors correlates with the proliferation rate of biliary tree during BDL. Indeed, after 
one or two weeks of BDL, proliferation prevails on apoptosis, whereas after BDL for three 
weeks, apoptosis prevails on proliferation. 
Our morphological results strongly suggest that BDNF plays a role in the remodeling of biliary 
tree during cholestasis and that it may be involved in the pathophysiology of cholestasic liver 
diseases.
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Introduction
Cholangiocytes were originally considered a “simple” epithelium lining the biliary 
tree. However, contrary to this classical opinion, the biliary epithelium plays import-
ant physiological functions in the modification of bile and in the detoxification of 
xenobiotics (Alpini et al., 1997a). Furthermore, cholangiocytes are the target cells in 
diseases of the biliary tree, such as primary sclerosing cholangitis, primary biliary cir-
rhosis and cholangiocarcinoma. 
Recent studies have highlighted the heterogeneity of biliary epithelium, at mor-
phological, functional and proliferative levels (Glaser et al., 2009). At morphological 
level, the biliary tree originates from the bile canaliculi and acquires a proper wall at 
the level of channels of Hering, extending to large extrahepatic bile ducts. The point 
at which the bile canaliculi continue with the canals of Hering is defined ductulo-can-
alicular junction. At the level of this junction, the wall of the biliary tract is partly 
formed by cholangiocytes and partly by hepatocytes. In this context, a compartment 
of partially undifferentiated cells, called hepatic progenitor cells (HPCs), has been 
identified. These cells constitute a stem cell compartment residing in the liver and 
able to differentiate towards cholangiocytes or hepatocytes (Cardinale et al., 2011). 
Cholangiocytes lining bile ductuli and canals of Hering are called “small cholangio-
cytes” because of the size and are coboidal, whereas cholangiocytes lining large bile 
ducts are called “large cholangiocytes” and are characterized by a columnar shape. 
These observations, originally made in humans, have been confirmed in several 
experimental studies, both in vivo and in vitro (Alpini et al., 1996; 1997a; Glaser et 
al., 2009). Cholangiocytes are also heterogeneous at functional level. In fact, “large 
cholangiocytes” possess an intense secretory activity and express the secretin receptor 
(SR; Alpini et al., 1997b). By contrast “small cholangiocytes” do not express SR and 
are involved in repairing biliary tree during chronic colangiopathies (Francis et al., 
2009). The heterogeneity of biliary epithelium has been shown, finally, at proliferative 
level. In fact, in the course of cholestasic liver diseases, as well as in experimental 
cholestasis in rats, the proliferative activity is restricted to “large cholangiocytes” and 
is closely associated with increased expression of SR and up-regulation of intracellu-
lar cAMP (Alpini et al., 1997b; 1998). By contrast, the proliferative activity of “small 
cholangiocytes” occurs upon toxic injury to the bile ducts and is mediated by the 
over-production of inositol trisphosphate (IP3; Alpini et al., 1998).
Proliferating cholangiocytes possess the peculiar capacity of acquiring a neuro-
endocrine phenotype (Roskams et al., 2004). This phenotypic switch is characterized 
by the expression of markers typical of neuroendocrine cells (chromogranin-A and 
neuronal cell adhesion molecule) and by the expression of glycolipids A2-B4 - lipidic 
molecules typical of neuronal and glial cytoplasmic membrane - and S-100 protein, a 
structural cytoskeletal protein expressed by glial cells (Popper et al., 1957; Roskams 
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et al., 1990; 1993; 2004; Desmet et al., 1995), the over-expression and secretion of sero-
tonin (Marzioni et al., 2005), endogenous opioid peptides and neurotrophins, and the 
increased cellular response to hormones and neuropeptides (Renzi et al., 2011). The 
acquisition of a neuroendocrine phenotype is of crucial importance in the physiopa-
thology of cholangiocytes (reviewed in Alvaro et al., 2008). However, little is known 
about the factors that induce the trans-differentiation of cholangiocytes into cells with 
neuroendocrine phenotype. In this regard, a relevant  role might be played by the 
action of neurotrophins, which could be also implicated in the modulation of prolifer-
ation of both small and large cholangiocytes during cholestasis.
The Brain Derivated Neurotrophic Factor (BDNF) is a neurotrophin mainly pro-
duced in the brain and closely related to neuronal plasticity, synaptogenesis and 
differentiation of serotonergic neurons (Nibuya et al., 1995; Sala et al., 1998; Duman 
et al., 2002; Fujioka et al., 2004; Rumajogee et al., 2006; Pinnock et al., 2010; Yoshii 
and Constantine-Paton, 2010). BDNF is also expressed by different subtypes of epi-
thelial cells (Peters et al., 2005; Ming et al., 2009; Prakash et al., 2010; Girard et al., 
2011). During development, it promotes the proliferation of bronchial epithelial cells 
(Prakash et al., 2010) and the development of neuro-epithelial lung bodies (Garcia-Su-
arez et al., 2009). Moreover, BDNF is expressed by many types of progenitor cells of 
neural  (review in Tonchev et al., 2011) and mesenchymal (Mousavi and Jasmin, 2006; 
Trzaska et al., 2009; Kompisch et al., 2010; Kan et al., 2011) origin, modulating their 
maturation and differentiation, and it is a trophic factor for endothelial cells (Dono-
van et al., 2000), promoting the proliferation, migration and differentiation of endo-
thelial progenitor cells (Zeng et al., 2012). 
BDNF binds to two classes of trans-membrane receptors: the tyrosine kinase 
receptor TrKB and the p75NT receptor. The activation of TrKB produces the increase 
of intracellular concentrations of cAMP and the recruitment of the MAPK/Erk path-
way, with a consequent activation of proliferation and cellular differentiation. By con-
trast, activation of the p75NT can activate the transcription factor NFκB, involved 
in cellular growth and trophism, as well as the JNK/c-Jun pathway, responsible for 
the transcription of pro-apoptotic genes (reviewed in Reichardt et al., 2006). The 
over-production of intra-cellular cAMP and the activation of the MAPK/Erk path-
way, which have been widely studied in view of neuronal plasticity, also constitute 
the major determinant for colangiocyte proliferation (review in Alvaro et al., 2007; 
2008; DeMorrow et al., 2008). In this regard, induction of cholangiocyte proliferation 
has been observed in vitro, using NGF, a neurotrophin homolog of BDNF from which 
NGF differs for the selective binding to TrkA, instead of TrKB (Gigliozzi et al., 2004; 
Alvaro et al., 2006). The activation of TrKB receptor correlates also with neuronal dif-
ferentiation and expression of serotoninergic markers by neurons (Ren-Patterson et 
al., 2005; Rumajogee et al., 2006). Since serotoninergic markers are also expressed by 
proliferating cholangiocytes (Marzioni et al., 2005), BDNF may be implicated in both 
proliferation and neuroendocrine trans-differentiation of cholangiocytes and hepatic 
progenitor cells (HPCs). 
Therefore, in the present study we have investigated the expression of BDNF and 
its receptors in the rat biliary tree, both in normal conditions and upon bile duct liga-
tion (BDL) for one, two or three weeks. BDL model is the most used model to study 
the proliferation of biliary tree in rodents, resulting in rapid proliferation of bile ducts 
with correlated increase of biliary cell mass which mimics human chronic cholestatic 
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liver diseases (Alpini et al., 1998). In these experimental conditions, we have correlat-
ed the expression of BDNF and its receptors with the proliferation-to-apoptosis ratio 
in biliary tree.
Methods
Experimental model of cholestasis
Twenty-four Wistar rats, males, 8 weeks aged and weighing about 225 g, were 
divided into four experimental groups consisting of 6 rats each:
Controls: not subjected to BDL;
BDL 1 week: subjected to BDL for one week;
BDL 2 weeks: subjected to BDL for two weeks;
BDL 3 weeks: subjected to BDL for three weeks.
The ligation procedure of the bile duct was carried out as previously described 
(Glaser et al., 2007). Before each experimental procedure the animals were anesthe-
tized with pentobarbital (50 mg/kg ip) and every effort was carried out to minimize 
any suffering and discomfort, in accordance with the recommendations for the use of 
laboratory animals of “Sapienza University of Rome” and in compliance with guid-
ance for use of laboratory animals of the NIH (NIH Publication nos. 85-23, revisited 
1996).
Processing of samples, Immunohistochemistry and immunofluorescence
Rat livers were fixed in 2% paraformaldehyde for 24 hours. Each liver was divid-
ed into blocks of 2-4 mm3, which were processed for embedding in paraffin and sec-
tioning into 3.5 µm thick sections with a rotary microtome.
After deparaffinization and rehydration, the sections were incubated with the pri-
mary polyclonal antibody in the following experimental conditions, specific for each 
antibody:
• sheep anti-BDNF (ab 75040 Abcam, Cambridge, UK), 1: 400, for 2 days at + 4 ° C;
• rabbit anti p75NTR (AB1554, Millipore, Temecula, CA), 1: 500, for 2 days at + 4 ° C;
• rabbit anti-TrKB (ab 51190 Abcam, Cambridge, UK), 1: 200, for 2 days at + 4 ° C;
• rabbit anti-pan cytokeratin (CK; cholangiocytes specific, comprising CKs 7-8 and 
7-20; Dako, Glostrup, Denmark), 1: 50, for one hour at room temperature;
• rabbit anti proliferating cells nuclear antigen (PCNA; Santa Cruz Biotechnology, 
Dallas, TX), 1: 50, for 60 minutes at room temperature.
In order to inactivate endogenous peroxidase, the incubation with primary anti-
body was preceded in all cases by preincubation with 3% H2O2 for 20 minutes at 
room temperature. On the sections treated for anti-pan CK, in order to expose the 
antigenic sites, the incubation was preceded also by enzymatic digestion with pro-
teinase K (Dako, Glostrup, Danmark), for 15 minutes at room temperature.
After incubation with the primary antibody the sections were incubated with 
the specific biotinylated secondary antibody, diluted 1: 1000, for 2 hours at room 
temperature, followed by incubation with peroxidase-coupled streptavidin (Dako, 
Glostrup, Danmark), for 20 minutes at room temperature. The immunoreaction was 
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revealed with by diaminobenzidine with a commercial kit (Dako), according to the 
instructions of the producer, controlling the yield under the microscope. The sections 
were then dehydrated in alcohol, cleared in xylene and mounted in an hydrophobic 
medium for light microscopy examination.
For double immunofluorescence labeling (BDNF + pan-CK), the sections were 
incubated simultaneously with primary antibodies diluted to the following concen-
trations: 1:100 (anti-BDNF) and 1:100 (anti pan-CK), overnight at + 4 ° C. Subsequent-
ly, the sections were incubated with byotinilated donkey anti sheep (Jackson Labo-
ratories, Berlingame, USA), diluted 1:500, for 2 hours, followed by incubation with 
Cy3--conjugated donkey anti rabbit IgG, diluted 1:400, and with Cy2-conjugated 
streptavidin (both from Jackson Laboratories, Berlingame USA), diluted 1:500. Finally, 
the sections were mounted in a specific mounting medium containing DAPI (Santa 
Cruz Biotechnology) and observed in a fluorescence microscope (Leica, Solms, Ger-
many).
TUNEL method for visualization of apoptotic cells
The TUNEL method was used for visualization of apoptotic cells following the 
instructions of the appropriate kit (Apoptag, Millipore, Temecula, California, USA).
Results quantification and data analysis
The percentage of cholangiocytes immune positive for BDNF and its receptors 
(TrKB, p75NT) among the total number of cholangiocytes was quantified by counting 
the cells positive to each antibody in different microscopic fields from each experi-
mental group.
Quantification of immunostaining for BDNF and its receptors (TrKB, p75NTR) 
was performed also by densitometry analysis of different microscopic fields from the 
four different experimental groups. A specific software (IAS, Delta Sistemi, Rome, Ita-
ly) was used as previously described (Casini et al., 2011). In brief, the optical densi-
ty of the reaction product was measured by light transmittance, assuming 0 value as 
maximum darkness, thus the maximal staining signal, and 100 as maximum bright-
ness, therefore the absence of signal.
The percentage of cells positive to PCNA (assumed as proliferating) or to TUNEL 
(assumed as apoptotic) on the total number of cholangiocytes were evaluated by 
counting positive cells in different microscopic fields and computing, for each experi-
mental group, the ratio between proliferation and apoptosis.
The mean percentage values of PCNA and TUNEL positive cells from different 
microscopic fields, +/- standard error, were  analyzed by ANOVA and t-test. Differ-
ences were considered significant for p<0.005.
Results
In normal rat liver BDNF appeared expressed by small and large cholangiocytes 
and by HPC (Fig 1). This finding was substantiated by double immunofluorescence 
labeling (Fig. 2, A-C) for BDNF (A, red) and biliary cytokeratins (CKs) (B, green), 
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Figure 1 – Immunolocalization of BDNF in normal rat liver (A), and in liver of rats subjected to one week (B), 
two weeks (C) or three weeks (D) BDL. Red arrows indicate large cholangiocytes, whereas yellow arrows indi-
cate small cholangiocytes. HPCs are evidenced in the squared areas. Quantification of BDNF immunostain-
ing in the different experimental groups, by counting BDNF positive cholangiocytes or by densitometry is 
reported in E and F, respectively. The differences among experimental groups were significant (p<0.005; 
ANOVA). Magnification: 40x.
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which are a validated marker of both cholangiocytes and HPC. Merged images (C, 
yellow) showed the colocalization of BDNF and CKs. There were no significative dif-
ferences in the immunostaining for BDNF among the different cellular subtypes of 
biliary tree (HPCs, small cholangiocytes and large cholangiocytes).
The intensity of BDNF immunoreactivity was different among experimental con-
ditons (Fig 1E,F). In detail: in normal rat liver (Fig 1A), a slight BDNF immunoreac-
tivity was detectable in cholangiocytes. After BDL for 1 week (Fig 1B), BDNF immu-
noreactivity was drastically increased both in small and in large cholangiocytes. After 
Figure 2 – Double immunolocalization for BDNF (A, red) and CKs (B, green). The merge figure (C) shows that 
BDNF and CKs are colocalized in cholangiocytes (arrowheads) and in some oval cells around the bile ducts, 
which are likely to be HPCs (arrows). Magnification: 40x.
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Figure 3 – Immunolocalization of TrKB (A) and p75NT (B) upon BDL. Red arrows indicate large cholangio-
cytes and yellow arrows indicate small cholangiocytes. HPCs are visible in the squared areas. Quantification 
of receptors immunostaining in the different experimental group, by counting positive cholangiocytes or by 
densitometry, is reported in C and D, respectively. The differences among experimental groups were signifi-
cant for both receptors (p<0.005; ANOVA). Magnification: 40x.
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two weeks BDL (Fig 1C) the results were similar to those upon one week BDL. Con-
versely, after three weeks BDL (Fig 1D), BDNF immunoreactivity was significantly 
reduced from that after one or two weeks BDL. In both normal and 3 weeks BDL rats 
liver, BDNF immunoreactivity was mostly confined to the basolateral membrane with 
only slight reactivity into the cytoplasm. 
Similar to BDNF, BDNF receptors (TrKB, p75NT) immunoreactivity was detected in 
small and large cholangiocytes and in HPCs (Fig 3A,B). Even for these molecules, no 
substantial difference in immunoreactivity was appreciated among the different cellu-
lar subtypes of biliary tree (HPCs, small and large cholangiocytes). As well as BDNF, 
Figure 4 – PCNA immunostaining in a control rat liver (A) and in the liver of a rat subjected to BDL (B). The 
percentage of cells positive to PCNA (i.e. proliferating) among the total number of cholangiocytes (C) was 
quantified by counting positive cells in different microscopic fields and obtaining a percent value for each 
experimental group (normal, BDL 1 week, BDL 2 weeks, BDL 3 weeks). The differences among experimental 
groups were significant (p<0.005; ANOVA). Magnification: 40x.
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both receptors were differentially expressed among experimental conditions. TrKB and 
p75NT immunoreactivities were drastically increased after one or two weeks of BDL 
(Fig 2C,D) as compared with normal rat liver. However, after one week of BDL, TrKB 
immunoreactivity resulted higher than that of p75NT, whereas after two weeks of BDL 
the immunoreactivity was almost the same for the two receptors. After three weeks of 
BDL, instead, the immunoreactivity for p75NT prevailed on that for TrKB; the latter 
was confined to the basolateral cell membrane. Therefore, the ratio between the immu-
nopositive cells for each BDNF receptor (TrKB/p75NT) yielded the following values: 
normal liver: 1; BDL 1 week: 2; BDL 2 weeks: 1; BDL 3 weeks: 0,2.
Figure 5 – TUNEL staining in a control rat liver (A) and in the liver of a rat subjected to BDL (B). The percent-
age of cells(positive to TUNEL (i.e. apoptotic) among the total number of cholangiocytes (C) was quantified 
by counting positive cells in different microscopic fields and obtaining a percent value for each experimental 
group (normal, BDL 1 week, BDL 2 weeks, BDL 3 weeks). The differences among experimental groups were 
significant for both receptors (p<0.005; ANOVA). Magnification: 40x.
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To search for possible relationships between the expression of BDNF and its 
receptors and the balance between proliferation and apoptosis of cholangiocytes, we 
labelled proliferating cells by PCNA immunostaining (Fig 4) and apoptotic ones by 
TUNEL (Fig 5). In normal rat liver, proliferation and apoptosis of cholangiocytes were 
substantially balanced, whereas prevalence of proliferation was detected in the rats 
submitted to BDL for one or two weeks. Conversely, after three weeks BDL we found 
prevalence of apoptosis. Quantitative data are summarized in Figs. 4C and 5C. The 
ratio between proliferation and apoptosis was obtained from that of PCNA positive 
to TUNEL positive cells, with the following results: normal liver: 1,1; BDL 1 week: 
1,46; BDL 2 weeks: 1,61; BDL 3 weeks: 0,18.
An inflammatory infiltrate was detected in the liver of rats upon BDL, more 
marked after three weeks than after one or two weeks BDL.
Discussion
The main findings of the present study are that: 1) BDNF and its receptors, TrKB 
and p75NT, are expressed by small and large rat cholangiocytes and by HPCs; 2) the 
expression of BDNF and its receptors changes with time upon BDL; 3) during BDL, 
the balance between the expression of BDNF receptors (TrKB and p75NT) correlates 
with that between proliferation and apoptosis of biliary epithelium.
The results were appreciated both in terms of positive cells and of intensity of 
immunostaining and suggest that neurotrophins, in particular BDNF, are involved in 
the pathophysiology of biliary epithelium during BDL.
The expression of neurotrophins in human and rat liver had been investigated in 
previous studies, with different results. Shibayama et al. (1996) failed to show any 
reactivity to TrK antibodies in human liver. Other studies, by RT-PCR or immunohis-
tochemistry on human or rat liver sections, found only trace levels of TrKB transcript 
or protein (Zhou et al., 1993; Yamamoto et al., 1996). Lomen-Hoerth and Shooter 
(1995) showed a low level of p75NT receptor in rat liver, using ribonuclease protec-
tion assay, but they were not able to show any TrKA or TrKB transcription. Finally, 
Gigliozzi et al. (2004) reported that the neurotrophin NGF, as well as its receptors 
TrKA and p75NT are expressed by normal rat cholangiocytes and overexpressed after 
one week of BDL. They also found that NGF stimulates the proliferation of cholan-
giocytes activating both Erk and IP3 intracellular pathways.
Among the different animal models mimicking cholestasic liver diseases and uti-
lized to investigate the mechanisms underlying cholangiocytes proliferation and bile 
duct damage, BDL is the most commonly used (Alpini et al., 1988; Glaser et al., 1997; 
Alpini et al., 1998). BDL induces proliferation of cholangiocytes, however prolonged 
BDL makes cholangiocytes also more susceptible to injury (Lesage et al., 2001; Alpini 
et al., 2003).
In the present study, we found that the expression of BDNF and of its receptors 
correlates with the remodeling of biliary epithelium during BDL. One week upon 
BDL we detected that PCNA expression prevailed on TUNEL reactivity, indicating 
that proliferation prevailed on apoptosis. Upon two weeks of BDL the expression 
of PCNA was increased in respect to one-week BDL, whereas only irrelevant dif-
ferences were detectable for TUNEL staining. On the contrary, after three weeks of 
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BDL, TUNEL reactivity was drastically increased, whereas only few cholangiocytes 
expressed PCNA. Therefore, one to two weeks after BDL cholangiocytes prolifera-
tion was prevalent and a low level of apoptosis occurs, whereas when BDL was pro-
longed to three weeks apoptosis became prevalent on proliferation. Three weeks after 
BDL we found an increased expression of p75NT and a reduced expression of TrKB. 
At previous time points, instead, the expression of TrKB prevailed (after one week), 
or was balanced (after two weeks) with that of p75NT.
Both TrKB and p75NT are receptors for BDNF (Rodriguez-Tebar et al., 1990; 
Frade and Barde, 1998; Reichardt et al., 2006). TrKB is a high affinity, tyrosine kinase 
receptor, specific for BDNF (Urfer et al., 1998; Wiesmann and De Vos, 2001), whereas 
p75NT is a low affinity receptor shared by different neurotrophins, including NGF, 
BDNF, NT3 and NT4. The molecular intracellular pathways activated by these two 
receptors are also different. TrKB is a tyrosine kinase transmembrane receptor which 
activates different pro-proliferative and growth pathways, including the Akt and Erk 
pathways, involved in the proliferation of large cholangiocytes (English et al., 1999), 
as well as the IP3/PKC pathway, responsible of the proliferation of small cholangio-
cytes (Huang and Reichardt, 2003). P75NT receptor, instead, belongs to the family of 
TNF receptors (Liepinsh et al., 1997; He and Garcia, 2004). It activates two distinct 
intracellular pathways one of which includes the activation of the cytoplasmic fac-
tor JNK and of the transcription factor c-JUN, with a pro-apoptotic effect (Chi et al., 
2005), whereas the other is characterized by the activation of the transcription factor 
NFκB and has pro-proliferative and differentiative properties (Hamanoue et al., 1999; 
Middleton et al., 2000). Activation of NFκB has been reported in cholestasis, possi-
bly to  reduce the effect of bile duct injury (Miyoshi et al., 2001). The activation of 
the pro-proliferative pathway, related to p75NT requires the coactivation of TrKB or 
of another neurotrophin tyrosine kinase receptor, such as TrKA or TrKC (Yoon et al., 
1998). Therefore, it is possible that, after one or two weeks of BDL, the coactivation of 
TrKB and p75NT neurotrophin receptors has a positive effect on proliferation of both 
small and large cholangiocytes and prevents apoptosis. Indeed, after two weeks of 
BDL, when the expression of these two receptors was balanced, we found the max-
imal proliferative activity, as detected by PCNA immunostaining. In contrast, after 
three weeks of BDL a prevalent expression of p75NT occurs and the activation of this 
receptor by BDNF may lead to the activation of a pro-apoptotic intracellular pathway, 
because of lack of coactivation of TrKB. Therefore, in the early stages of BDL, BDNF, 
which is directly produced by small and large cholangiocytes, can stimulate prolifer-
ation of biliary epithelium and exert an anti-apoptotic effect, whereas at later stages, 
its production by cholangiocytes decreases drastically and the small amount secret-
ed can induce apoptosis through activation of p75NT without coactivation of TrKB, 
which results less expressed. These results, obtained in the liver, are in line with 
those obtained in the nervous system, where survival, apoptosis, differentiation and 
response to injury are all controlled through the modulation of the above described 
signaling pathways activated by neurotrophins (Patel et al., 2000; Teng et al., 2005).
The expression of TrKB in the cytoplasm of proliferating cholangiocytes likely rep-
resents the intracellular trafficking of the receptor. Binding of neurotrophins to their 
TrK receptors, in fact, induces the formation of signaling endosomes, containing both 
the neurotrophin and the receptor, the latter trafficking between the cell surface and 
the cytoplasm (Makkerh et al., 2005; Arevalo et al., 2006). The fact that, after three 
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weeks of BDL, TrKB seems localized mainly at the basolateral cell surface, suggests 
that this receptor may not be activated by BDNF, further supporting the hypothesis 
that upon prolonged BDL the activation of p75NT occurs without coactivation of TrK 
receptors, exerting a pro-apoptotic effect.
Proliferating cholangiocytes acquire a neuroendocrine phenotype and secrete and 
respond to a number of hormones, neurotransmitters and neuropeptides, including 
neurotrophins (Roskmas et al., 2004; Renzi et al., 2011). The formation of this neuro-
endocrine compartment predominated by cholangiocytes represents a unique oppor-
tunity for these cells to regulate their own proliferation via autocrine pathways and 
to influence other nearby cell types, such as vascular endothelial cells, portal fibro-
blasts, stellate cells and HPCs (Alvaro et al., 2007). In our study we found that BDNF 
and BDNF receptors are expressed by HPCs, which were identified according with 
Forbes et al. (2002). The expression of BDNF and BDNF receptors by HPCs during 
BDL may be part of this neuroendocrine-paracrine crosstalk. On the other hand, 
HPCs expressing BDNF and BDNF receptors might represent a subpopulation of 
these cells committed to a neuroendocrine phenotype.
Besides HPCs, proliferating cholangiocytes crosstalk with other cellular subtypes, 
including lymphocytes, macrophages and other inflammatory cells (Alvaro et al., 
2007). In human pathology, as well as in experimental models of cholestasis, in fact, 
proliferation of cholangiocytes occurs always associated with marked changes in sur-
rounding mesenchymal cells and extracellular matrix (Lazaridis et al., 2004). In chronic 
cholestatic liver diseases (primary biliary cirrhosis, primary sclerosing cholangitis), it 
occurs in a milieu of an intense portal inflammation (Fava et al., 2005). Inflammatory 
cells produce interleukins (IL-1, IL-6, IL-8, INF-γ), TGF and TNF which are involved 
in the remodeling of biliary tree, as well as in the genesis of peribiliary fibrosis (Alva-
ro et al., 2007). In particular TNF can induce apoptosis of cholangiocytes, by activat-
ing its transmembrane receptor which activates, in turn, a pro-apoptotic intracellular 
signal (Loffreda et al., 1997; Rosen et al., 1997; Guicciardi and Gores, 2009). p75NT is 
member of the TNF receptor superfamily (Liepinsh et al., 1997; He and Garcia, 2004). 
After three weeks of BDL, we have found high expression of p75NT, together with 
decreased expression of TrKB and BDNF. The activation of the p75NT may contrib-
ute to the apoptosis of cholangiocytes, for which BDNF may cooperate with inflam-
matory cytokines and TNF. Moreover, the decreased production of BDNF by cholan-
giocytes might exacerbate this process because BDNF has an anti-inflammatory effect 
(Gigliozzi et al., 2004). All these mechanisms could contribute to ductopenia occurring 
in cholestasic liver diseases as well as in late stages of BDL models. 
In conclusion, we should like to stress the original aspects of this immunohisto-
chemical study: 1) it is the first study focused on the expression of the neurotrophin 
BDNF and of its receptors (TrKB, p75NT) in rat liver; 2) it shows, for the first time, 
that the expression of BDNF and of related neurotrophins receptors is closely associ-
ated with the proliferation as well as with the apoptosis of biliary epithelium, being 
a possible determinant for remodeling of biliary tree during BDL; 3) it reports that 
BDNF and its receptors are expressed by HPCs during proliferation of cholangio-
cytes, suggesting that, as well as in the brain, neurotrophins, including BDNF, could 
modulate the HSCs compartment and intervene in the restoration of liver damage.
These findings call for more detailed investigations on neurotrophic signal in the 
liver, and lay the bases for new insights on the application of neurotrophins in the 
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management of chronic cholestasic liver diseases, as well as in the modulation of 
HPCs compartment.
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